Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal antibody
Buy 6 'Safer' Dividend Dogs Of 23 January Barron's Better Bets Than T-Bills
06:28am, Thursday, 09'th Jan 2025
Seven of the ten lowest-priced BBB Dogs, including Altria, Pfizer, and Verizon, are ready to buy, with dividends from $1K invested exceeding single share prices. Analysts project 16.27% to 32.98% net
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
06:51pm, Wednesday, 08'th Jan 2025
Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% change compared to its last close.
Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer
12:13pm, Wednesday, 08'th Jan 2025
The latest dividend declarations, combined with stock price movements, have pushed PFE's yield to be almost twice as JNJ's. But I want to caution you to look beyond yield (and P/E too) and examine oth
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
05:48am, Wednesday, 08'th Jan 2025
It might seem that valuation is no longer important for investors. Stocks that have sky-high valuation metrics continue to soar.
GSK and Pfizer's RSV vaccines to carry warnings of neurological disorder risk
06:20pm, Tuesday, 07'th Jan 2025
GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on Tu
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 07'th Jan 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
10:16am, Tuesday, 07'th Jan 2025
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
Large-Cap Value Stocks Could Rule in 2025: 4 High-Yield Dividend Winners
06:41am, Tuesday, 07'th Jan 2025
According to BTIG Research, value stocks are closing at a 40-year low relative to growth.
Investing $50,000 in Each of These 5 Stocks Could Make You Nearly $17,500 in Passive Income in 2025
05:46am, Tuesday, 07'th Jan 2025
If generating more passive income is one of your New Year's resolutions, you have plenty of options for achieving the goal. One of the easiest is to buy high-yield dividend stocks.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Monday, 06'th Jan 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at
4 of the Highest-Yielding S&P 500 Stocks for 2025 With 6% and More Dividends
04:46pm, Sunday, 05'th Jan 2025
Dividend stocks are a favorite among investors for good reason.
Is Pfizer Stock Undervalued at Current Prices?
03:30am, Sunday, 05'th Jan 2025
Pfizer (PFE -0.07%) stock investors are curious about the valuation and prospects for the healthcare company.
High-Yield Dividend Stocks Rebound in 2025: These 5 Pay 5% and More
10:18am, Saturday, 04'th Jan 2025
Dividend stocks are a favorite among investors for good reason. They provide a steady income stream of passive income and offer a promising avenue for total return.
Should You Buy Pfizer Stock Right Now in 2025?
12:16pm, Friday, 03'rd Jan 2025
Pfizer (PFE 0.20%) is an interesting healthcare company with excellent prospects for cash flow growth.
